To improve the website's functionality, we use cookies, including third-party cookies. Read our Privacy Policy for more information

I Agree

Prefilled Auto Injectors Market

Prefilled Auto Injectors Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022

Analysis of Prefilled Auto Injectors market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Introduction

Growing preference for convenient injection of anticoagulants and the introduction of a spectrum of new biotech products is reflecting favorably on the global prefilled auto-injectors market.

Over the next couple of years, use of prefilled auto-injectors is expected become widespread across the globe.

The product has made self-inject procedures extremely convenient for patients, hence, gaining a significant amount of user trust. In addition, the next generation prefilled auto injectors are more advanced in terms of technology and design.

Manufacturers are actively focusing on perfecting prefilled auto-injectors in order to facilitate their use in new therapeutic areas.

Prefilled auto-injectors are essentially developed for more reliable and accurate injection. Factors as such are anticipated to further boost the global sales of prefilled auto-injectors. As per the latest report published by Fact.MR, the global prefilled auto injectors market is will surge at 15.3% CAGR during the forecast period (2017-2022).

Prefilled auto-injectors are primarily intended for self-administration by patients without the obligation of any special training. These injectors come with standard prefilled barrels that contain therapeutic drugs and are easy to use.

By design, they are mostly compact and have a pen like shape with a tiny reusable needle attached on the nip. Usually, the site of injection is either thighs or arms, but it may differ on a case-by-case basis or dosage of drug.

Don't Need a Global Report?

Save 40% on Country & Region specific reports

North America Will Continue to Spearhead the Global Prefilled Auto-Injectors Market

In terms of revenue, North America is expected to dominate the global prefilled auto-injectors market over 2022. This is primarily owing to the rising number of patients who require drug administration on regular basis.

Owing to the extreme convenience of administrating insulin, prefilled auto injectors are also gaining popularity among patients suffering from diabetes in the region.

The prefilled auto injectors market in North America in expected to witness a strong growth over the forecast period.

Meanwhile, robust development of the healthcare sector coupled with low cost of prefilled auto-injectors is proving to be instrumental for the growth of the market in Asia-Pacific excluding Japan (APEJ). Between 2017 and 2022, the region’s market is projected to increase at an impressive CAGR of 15.9%.

Based on indication, the anaphylaxis segment currently accounts for more than two-third revenue share of the market.

The segment is estimated to reach a market valuation of over US$ 3,187 Mn towards the end of 2022, reflecting a strong CAGR. In addition, the segment is expected to growing at around US$ 320 Mn annually over the course of the assessment period.

Prefilled Auto Injectors Market

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Competition Tracking

Fact.MR’s report also profiled companies that are expected to remain active in the expansion of global prefilled auto injectors market through 2022, which include

  • Becton
  • Dickinson and Company
  • Pfizer Inc.
  • Mylan N.V.
  • Antares Pharma Inc.
  • Amgen Inc.
  • Eli Lilly
  • Company.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Market Taxonomy

Indication
  • Anaphylaxis
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • Others
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

- Premium Report Details -

Prefilled Auto Injectors Market
  • FACT169MR
  • Mar-2022
  • Healthcare
  • 170 Pages
  • 155 Tables
  • 51 Figures

- Let's Connect -

Talk To an Expert Today Connect

- Get Started -

Get insights that lead to new growth opportunities

Buy Now

Get A Special pricing for start-ups and universities

Enquiry Before Buying

- Humble, Yet Honored -

Our prestigious clients

- Research Methodology -

An Adaptive Approach to Modern-day Research Needs

Get Methodology

- FAQs -

The global Prefilled Auto Injectors market is likely to reach a valuation of US$ 3,616 Mn by the end of 2022.

Some of the key players in global Prefilled Auto Injectors market are Eli Lilly and Company, Becton, Dickinson and Company, Mylan N.V., Amgen Inc., Pfizer Inc. and many more.

Exclusive Report

Need An Exclusive Report For Your Unique Requirement?

Google translate